senior fellow, Hoffberger Center for Professional Ethics
senior research associate, Schaefer Center for Public Policy
senior fellow, Center on Drugs and Public Policy, University of Maryland School of Pharmacy
M.P.H., Sc.D., The Johns Hopkins University
CERT, University of Maryland, University College
B.S. Pharm., University of Maryland
B.A., Loyola College
Alan Lyles' C.V. (.pdf)
Alan Lyles is the Henry A. Rosenberg Professor of Public, Private and Nonprofit Partnerships and a professor in the College of Public Affairs' Health Systems Management program. He is also a fellow of the National Academy of Public Administration and a docent of pharmaceutical policy and pharmacoeconomics at the University of Helsinki and he has published and lectured extensively in the United States and abroad.
Lyles' professional interests focus on pharmaceutical economics and health policy—particularly on managing drug supply, distance education and professional practice communities, and lifestyle consequences for health. He serves on several editorial boards: Clinical Therapeutics, for which he is also section editor for Pharmaceutical Economics and Health Policy; Drug, Healthcare and Patient Safety; and Biotechnology Healthcare. Lyles is co-editor of Obesity, Business and Public Policy (2007), and his views on public and private policy interventions to mitigate obesity have been reported in The New York Times. He has been a visiting chair of pharmacoeconomics (2006) and a Fulbright Senior Specialist (2007) at the University of Helsinki.
Lyles' operations experience with health service delivery includes administrative work in Johns Hopkins Hospital's Comprehensive Alcoholism Program and as general manager of its Outpatient Department (1970s); administrator of the Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University, School of Medicine (1980s); executive assistant to the dean and vice president for medicine and assistant dean for planning and analysis, Johns Hopkins University School of Medicine (1990s). He has been chair of the Maryland Drug Use Review Board, chair of the Association of American Medical Colleges’ Group on Institutional Planning, president of Delta Omega, Alpha Chapter—a national public health honor society, and he is currently chair of the Nominating Committee for the National Academy of Public Administration.